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The Caulobacter crescentus FlbD protein acts at ftr sequence
elements both to activate and to repress transcription of cell
cycle-regulated flagellar genes
(RNA polymerase/ou promoters/DNA footprintlng)

ANDREW K. BENSONt, GiRIJA RAMAKRISHNANtt, NORIKO OHTAt, JUNLI FENG§, ALEXANDER J. NINFAt§,
AND AUSTIN NEWTONtII
tDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544; and IDepartment of Biochemistry, Wayne State University, Detroit, MI 48201
Communicated by Sydney Kustu, February 25, 1994

presumably recognized by a novel RNA polymerase holoenzyme, designated here Eay.
Transcription by Ea54 in Salmonella typhimurium and
other bacteria depends on its interaction with specific activator proteins that typically bind to DNA sequence elements
4100 bp upstream of the transcriptional start site (17).
Genetic analysis has identified analogous cis-acting sequences termed ftr (flagellar transcription regulator) elements in C. crescentus that control the timing of transcription
from the a54-dependent level III and IVfla genes (7-12, 18,
19). Another member ofthisftrfamily,ftr4, overlaps the level
IIfliF promoter and is required to turn offfliF transcription
at the end of its synthetic period (3). The FlbD protein
described by Ramakrishnan and Newton (20) is one candidate
for the transcription factor acting at theseftr sequences. The
flbD gene is essential in vivo for transcription regulation of
level III and IVfla genes (1), it encodes a predicted protein
homologous to the o54-dependent gene transcription activator NtrC (17), and it is sufficient to activate transcription from
the cloned flbG promoter in Escherichia coli (20). Mobilityshift experiments (21) also suggest that the FlbD protein binds
to an ftr sequence within the flbG promoter.
Here we show that FlbD is in fact a sequence-specific
DNA-binding protein that recognizes conserved bases inftr
sequences. We have used a purified C. crescentus RNA
polymerase that initiates transcription from thefliF promoter
and a reconstituted Er4 from E. coli that recognizes theflbG
promoter to demonstrate that FlbD acts at ftr sequence
elements both to activate transcription from the level III
o54-dependent flbG promoter and to repress transcription
from the level II oy-dependentfliF promoter. Thus, FlbD is
a key switch protein in the fla gene hierarchy mediating the
transition from level II to level m transcription.

ABSTRACT
The faeilar genes (fla genes) in Caulobater
crescentus are organized Into a regulatory hierarchy of four
levels, I-IV, in which transcription of the class III and class IV
genes late In the cell cycle from o-"-dependent promoters
depends on expression of the class I genes above them. Timing
of fla gene expression has been attributed to sequential activation and repression by specilfc tnscription factors. Here we
report that purified FlbD activates transcription in vitro from
the am-dependent class JJflbG promoter and represes transcription from the class U iliF promoter by bing to fir
(fageflar transcription regulator) sequence elements required
for their transcriptional regulation in vivo. The FIbD protein
at three highly conmakes symmetrical base-specific
served ane nucleotides in each half site offkr) andftrl at
flbG and the singlefb4 site atfliF. The dual function of FlbD
in activation of class m genes and repression of the class HflF
promoter Is consistent with a central role of FlbD as a switch
protein meating the transition from level I to level m fib
gene expression.

During each cell division, the bacterium Caulobacter crescentus differentiates to produce a sessile stalked cell and a
motile swarmer cell. Swarmer cell differentiation is marked
by flagellum biosynthesis at one pole of the predivisional cell
through sequential activation and repression of flagellar
genes (fla genes) during the cell cycle. The order offla gene
expression corresponds to the sequence of their assembly
into the flagellum. The fla genes are organized into a transcriptional hierarchy of levels I-IV in which expression of
genes at each level depends upon genes at levels above them
in the hierarchy (1-3). Level I genes at the top of the
hierarchy have yet to be identified, but they are presumed to
encode products that respond directly to cell cycle signals
and are required for expression of class IIA and IIB genes at
the next lower level (3). Components of the flagellar basal
body, as well as proteins that are involved in flagellar
protein-specific export, are encoded by genes at level II (refs.
4-6; G.R., J. Zhao, and A.N., unpublished work), whereas
genes encoding the axial filament, hook, and flagellar filament occupy the two lowest levels of the hierarchy (levels III
and IV; refs. 7-13).
A role for specialized RNA polymerase holoenzymes in
governing the timing offla gene transcription was originally
based on the observation that genes at levels III and IV of the
hierarchy are transcribed by o54 RNA polymerase (Eo54)
(7-15). Class IIB promoters, which are transcribed earlier in
the cell cycle, bear little or no resemblance to e4, 7O, or
other described bacterial promoters (3, 5, 6, 9, 16) and are

EXPERIMENTAL PROCEDURES
Protein Purification. E. coli core RNA polymerase (22) and
a54 (23) were purified as described. Integration host factor
(IHF) was purified by the procedure of Surette and Chaconas
(24). The flbD gene was overexpressed in a T7 expression
system using plasmid pET3-b (25). FlbD was purified from
=30 g (wet weight) of cells by disruption in a French pressure
cell, ammonium sulfate precipitation at 43% saturation, and
column chromatography on DEAE-Sephacel and heparinSepharose in 20 mM Tris, pH 7.9/5% (vol/vol) glycerol/0.1
mM EDTA/0.1 mM dithiothreitol. The purified protein was
Abbreviations: Eo54, RNA polymerase holoenzyme containing a54;
IHF, integration host factor.
*Present address: Department of Medicine, University of Virginia,
Charlottesville, VA 22908.
'Present address: Department of Biological Chemistry, University of
Michigan, Ann Arbor, MI 48109.
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specifically recognizes firl of flbG and ftr4 of fliF, we used
both DNase I footprinting and dimethyl sulfate protection/
enhancement assays. Binding of FlbD to the firl sequence
element of the Eo54-dependentflbG promoter was monitored
with a restriction fragment of the divergent flbG-flgK promoter region (Fig. 1B). Our FlbD preparation showed strong
DNase I protection at three distinct regions (Fig. 2A): (i) a
40-bp region extending from -126 to -86 of flbG which
includes the ftrl sequence identified genetically by Mullin
and Newton (10, 12) at -117 to -101, (ii) a region adjacent
toftrl at -155 to -133 which we have designatedftrl*, and
(iii) a region of protection that corresponds to the location of
ftr2 and ftr3 in the flgK promoter region where FlbD would
also be expected to bind (12, 18). Inspection of the ftrl*
sequence has shown that it can be aligned withfirl),ftr2,ftr3,
andftr4; its possible role is considered in the Discussion. We
could not determine the precise extent of protection atftr2
and ftr3 in this experiment due to lack of resolution near the
top of the gel.
Dimethyl sulfate methylation protection/enhancement assays identified several FlbD contacts at ftr) and ftrl* (Fig.
2B). Methylation-dependent cleavage of guanine residues at
-104, -113, and -114 offir) and at -137, -146, and -147
of ftrl* was reduced by bound FlbD, whereas cleavage at
adenine at position -119, which lies between fir) andfltr*,
became hypersensitive. These FlbDguanine contacts atftrl
and ftrl* are illustrated in Fig. 1C.
Repression of transcription from the class IIB fliF promoter depends upon theftr4 sequence that extends from -14
to +3 (Fig. 1 and ref. 3) and the gene encoding FlbD (1), which
lies at the end of thefliF operon. DNase I footprinting assays
(Fig. 3A) showed that FlbD protected a 20-bp region (-15 to
+5) that includes the ftr4 sequence. The specificity of the
FlbD interaction with ftr4 was confirmed by examining the
effects on FlbD binding offii4 mutations known to derepress
fliF expression in vivo (3). Mutant promoters with a T G
change at residue -15 (AKC1) and a deletion of the guanine
residues at -13 and -12 (AKC2) decreased the ability of
FlbD to protectftr4 from DNase I cleavage (Fig. 3A). Further
analysis of FlbD binding atftr4 by dimethyl sulfate protection
assays (Fig. 3B) revealed a pattern of protection (positions
-14, -13, -12, and -3) that was similar to that observed at
firl and ftrl* (see Fig. 1C for comparison). The similarity of
the FlbD contacts at firl, ftrl*, and ftr4 provides strong
evidence that their function in vivo depends upon binding of
the FlbD protein.
FlbD Is an Activator of - epedet raspon in
Vitro. The C. crescentusflbG and flgK promoters are recognized by E. coli Eao', and in the presence of NtrB and NtrC

>95% pure as judged by Coomassie blue staining of SDS/
polyacrylamide gels and identified as FlbD by N-terminal
amino acid sequence analysis (G.R., unpublished data).
C. crescentus RNA polymerase was extracted (22) from
4100 g (wet weight) of cells and purified by chromatography
on heparin-Sepharose, Bio-Rad A-1.SM, and singlestranded-DNA-cellulose. The DNA-cellulose fractions were
tested for activity on the 290-bp BamHI-HindIII fragment of
the fliF promoter by run-off transcription assays (Fig. 1B).
FootprintIng Procedures. Footprinting probes (Fig. 1B)
were derived from pNJ5 (flbG-flgK promoter region; ref. 14)
and pGIR125 (fliF promoter). Derivatives of the 290-bp
BamHI-HindIII fragment of fliF carrying mutations in the
ftr4 element were constructed by site-directed mutagenesis
using oligodeoxynucleotide AB3 (5'-GGATTTACCCCGTACAAGGT-3') to construct pAKC1 and oligodeoxynucleotide
AB5 (5'-GCAGGATTTACAGTACAAGG-3') to construct
pAKC2.
DNase I and dimethyl sulfate footprinting reactions were
performed essentially as described (26, 27). Binding reactions
were carried out in 20 j1 at 34WC in transcription buffer (50
mM Tris, pH 7.5/10 mM MgCl2/50 mM KCl/0.1 mM
EDTA/1 mM dithiothreitol). The cleavage products were
resolved in 6% polyacrylamide sequencing gels and visualized by autoradiography.
Transcription Assays. Transcription assays on supercoiled
plasmid templates were performed at 34WC as described (28).
Purified reagents were added in the following concentrations:
core RNA polymerase, 100 nM; o54, 200 nM; NtrB, 160 nM;
NtrC, 400 nM; template, 5 nM. FlbD and IHF were added
sequentially after the addition of template DNA and RNA
polymerase. Run-off transcription assays were performed in
50 p1 of transcription buffer with 3 pg of the C. crescentus
RNA polymerase preparation. After 20 min of incubation at
34PC, 5 XCi (185 kBq) of [e-32P]UTP was added along with
GTP, ATP, CTP (0.4 mM each), UTP (0.2 mM), and heparin
(100 pug/ml). The reactions were terminated by ethanol
precipitation after an additional 10 min of incubation. FlbD
was added to the reactions after the addition of template and
RNA polymerase. The transcripts were resolved in 8%
polyacrylamide denaturing gels and visualized by autoradiography.

RESULTS
FibD Binds Spc ly tofir Elements fr), ftrl*, andft4.
The 19-bp sequence elements ftr), ftr2, ftr3, and ftr4 share
residues that are either invariant or highly conserved at 12 of
17 positions (Fig. 1). To determine whether the FlbD protein
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FIG. 1. ftr sequences of the flbG-flgK and fliF promoter regions. (A) Organization of the fliF, flbG, and flgK transcription units. Arrows
drawn from-theflbD coding region illustrate positive (+) and negative (-) regulation. (B) Maps of the 650-bp EcoRI (E)-Hindffl (H) frgent
of the flbG-flgK promoter region and the 290-bp BamHI (B)-HindIII (H) fragment of the fliF promoter used in these studies. (C) Nucleotide
sequence of theftr elementsftrl, ftr2, fr3, and fl4 with their positions relative to the transcriptional start sites labeled. Symmetrical guanines
of theftr sequences that are protected from methylation with dimethyl sulfate by FlbD are indicated by a circle above or below the base (data
for bottom strand not shown).
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FiG. 2. Footprinting of the purified FlbD protein to theflbG-flgK
promoter region. The probe for A and B was the 650-bp EcoRIHindmI fragment of pNJ5 labeled at the HindU site with Klenow
DNA polymerase. (A) DNase I protection pattern in the absence
(lane 1) or presence (lanes 2-5) of MlbD. (B) Dimethyl sulfate
methylation protection/enhancement assays in the absence (lane 5)
or presence (lanes 1-4) of FlbD. The final concentration of FlbD (nM)
is indicated above each lane. Lanes labeled G+A contained products
of Maxam-Gilbert G + A sequencing reactions. Nucleotides numbered in A are the endpoints of the regions protected from DNase I
cleavage whereas those in B correspond to those guanine and adenine
residues where dimethyl sulfate-dependent methylation was either
inhibited or enhanced.

transcription is initiated in vitro from the same start utilized
by Caulobacter RNA polymerase in vivo (14). Because
genetic experiments have shown that flbG transcription requiresflbD and an intactftrl and is stimulated =5-fold by the
presence of the ihfl and i/J2 binding sites (10, 12, 18, 19, 29),
we examined whether transcription from the flbG promoter
in our in vitro assay system would depend on purified FMbD,
the firl sequence, and IHF.
Single-cycle transcription assays were performed with
supercoiled template plasmids that carried the restriction
fragment used for footprinting of ftr) (Fig. 1B). In plasmid
pNJ5, the flbG transcription start site lies 365 nt upstream
from the 17 Rho-independent terminator (14). Addition of
NtrB and NtrC to the reaction mixtures gave the expected
365-nt transcript (Fig. 4, lane 1). When FlbD was substituted
for NtrB and NtrC (lanes 3-9), it also activated transcription
by the E. coli Ea54 and generated a transcript that was
identical in size. The presence of NtrB, which is essential for
NtrC-dependent activation, had no effect upon the ability of
FlbD to activate flbG transcription (compare lanes 3 and 4).

FIG. 3. Footprinting of the FlbD protein at the fliF promoter
region. (A) DNase footprinting. Probes for these assays were the
290-bp BamHI-HindllfliF promoter fiagments from pGIR125 (wild
type, lanes 1-4), pAKC1 (-15 TV- G mutant, lanes 5-8), and pAKC2
(deletion of guanines at -14 and -13, lanes 9-12) labeled at their
Hindsl sites with Klenow DNA polymerase. The final concentration
of FlbD (nM) is indicated above the appropriate lanes. Nucleotides
corresponding to the endpoints of DNase I protection relative to the
transcriptional start site of fliF are shown. (B) Dimethyl sulfate
methylation protection/enhancement assay using the wild-type fragment inA. FlbD was added to afinal concentration of400 nM. Shown
in the three lanes at right are products of Maxam-Gilbert sequencing
reactions that were derived from the same labeled fragent. The
numbered nucleotides at left correspond to the positions of guanine
residues protected from methylation by FlbD.

Based on intensity of the labeled bands, addition of E. coli
IHF along with FlbD resulted in %5-fold higher levels of the
transcript than with the FlbD protein alone (Fig. 4, lanes 7-9).
Introduction of a single base change inftr) (G -* T at -113
in pAKC5), which dramatically reducesflbG transcription in
vivo (10, 12), eliminated FlbD-dependent transcription from
the flbG promoter in vitro (Fig. 4B, laies 3 and 4), whereas
activation by NtrC was unaffected (compare Fig. 4B, lane 1
with Fig. 4A, lane 1). Activation offlbG transcription by high
concentrations of NtrC does not depend upon the firl sequence (14) and probably results from NtrC binding nonspecifically to the template DNA.
FUbD Inhibits Transcription of theJWF Promoter in Vito. A
simple model for negative autoregulation offliF transcription
is that binding of FlbD toftr4 (Fig. 3), which overlaps thefliF
transcriptional start site, inhibits transcription. To test this
model directly, we examined the ability of FlbD to inhibit
transcription from thefliF promoter in vitro. Because thefliF
promoter and other class IIB promoters appear to be different
from other prokaryotic promoters (3, 5, 6, 16), we purified an
RNA polymerase activity from C. crescentus cells based on
its specificity for transcription from the oy-dependent promoter of fliF (Materials and Methods).
The specificity of fliF promoter recognition was tested by
run-off transcription assays with two fliF templates (3) that
differed at their 3' termini by 18 nt with respect to the in vivo
transcription start site (Fig. 5). The transcripts generated
from these template fragments migrated very close to the
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FIG. 4. Activation offlbG transcription in vitro by FlbD. Singlecycle transcription assays were performed with plasmids pNJ5 (wild
type) (A) and pAKC5 (-113 G

--*T)

(B) in which the flbG promoter

was fused 365 bp upstream of the Rho-independent terminator of the

parental plasmid pTE103 (30). The final concentration of FlbD (pM)
is shown above each lane. IHF was added (100 nM) to the reaction
mixtures for lanes 7-9 of A and lanes 2-4 of B. End-labeled Sau3 Al
fragments of pUC18 were run in lane M as size markers.

expected 102-nt and 84-nt lengths (Fig. 5, lanes 1 and 2).
Promoter specificity was examined with a mutant template
(deletion of nucleotides -24 and -25) that substantially
reduces in vivo transcription of fliF (3). The amount of the
expected 102-nt run-off transcript from the mutant template
(Fig. 5, lane 4) was reduced relative to the wild type (Fig. 5,
lane 1). Thus, the Caulobacter RNA polymerase preparation
used in our studies requires sequence elements in the fliF
promoter region that are identical to those required in vivo.
When FlbD was included in the run-off transcription reaction with a wild-type template (Fig. 5, lane 3), the 102-nt
transcript that was observed in its absence (Fig. 5, lane 1) was
eliminated. These results are consistent with previous genetic
findings thatflbD negatively autoregulatesfliF expression (1)
and support the conclusion that FlbD acts during the cell
cycle as a negative switch to turn off synthesis of flagellar
basal body proteins encoded by the fliF operon.
DISCUSSION
These studies provide compelling evidence that FlbD is a key
regulator in the periodic expression of flagellar genes in the
C. crescentus cell cycle. The FlbD protein turns off transcription from the oy-dependentfliF promoter at level II and
activates transcription from o54-dependentflbG promoter at
level III of thefla gene hierarchy. The function of FlbD as a
positive and negative regulator is mediated by a family of
cis-acting DNA sequences designated as ftr.
FHbD Is Both an Activator and a Repressor of fla Gene
Transcri
FlbD-dependent activation of flbG transcription by the reconstituted Eo54 required an intact firl sequence and was stimulated by IHF (Fig. 4). These results are
in complete agreement with previous genetic analyses of the
functions of theftrl, ihfl, and if sequence elements (9, 10,
12, 18, 19, 29). The activity of FlbD as a repressor was
demonstrated by using an RNA polymerase purified from C.
crescentus that recognizes the ory promoter of the fliF gene
(Fig. 5). Moreover, full inhibition of fliF transcription by
FlbD depended on an intactftr4 sequence element located at
-15 to +5 (unpublished data). These observations are consistent with genetic results showing that mutations in either
flbD or ftr4 increase fliF transcription by 5- to 10-fold (refs.
1 and 3; G.R., J. Zhao, and A.N., unpublished results).
.

FIG. 5. In vitro run-off transcription assays using fliF promoter

fragments derived from pUC18SV4 and pUC18SV4#4. Each carries
the 290-bp BamHI-HindI fragment of the fliF promoter (Fig. 1B)
that has been filled in with Klenow DNA polymerase and ligated to
the Hincd site of pUC18 (3). pUC18SV4#4 carries a deletion of the
TA residues at -24 and -25 relative to the fliF promoter (3).
Template fiagments were present at -5 nM as follows: lane 1,
pUC18SV4 BamHI-HindIll fragment; lane 2, pUC18SV4 BamHIPst I fiagment; lane 3, pUC18SV4 BamHI-HindIII fiagment with
FlbD protein added at 1 pAM; lane 4, pUC18SV4#4 BamHI-HindIll
fragment. End-labeled Sau3 Al fiagments of pUC18 were loaded in
lane M as size markers. The expected sizes of rn-off transcripts
from the BamHI-HindIII fiagment and the BamfH-Pst I fragment
are 102 nt and 84 nt, respectively, relative to the in vivo transcriptional start site (3).

Regulation of F1bD Activity. Sequence homology of FlbD to
the family of response-regulator proteins suggests that its
activity could be regulated by phosphorylation (31, 32),
despite the absence of three conserved residues that are
signatures of this protein family (20). Phosphorylation of the
homologous Eo54 activator, NtrC, enhances its cooperativity
in DNA binding and is critical for its ability to catalyze ATP
hydrolysis (33-35). We have recently observed that the
high-energy phosphate compound phosphoramidate potentiates activation of transcription from the flbG promoter by
FlbD (36) and that FlbDsl40F, which contains a substitution
(Ser140 - Phe) corresponding to that in the constitutively
active NtrC protein NtrCsl60F (33), is a better activator of
transcription in vitro than wild-type FlbD (36). In addition,
Wingrove et al. (21) have recently detected the phosphorylation of an epitope-tagged FlbD protein late in the C.
crescentus cell cycle, when class III and IV fla genes are
transcribed.
The capacity of FlbD to activate flbG transcription and
repressfliF transcription is subject to two distinct pathways
of control. Activation of level IIIflbG transcription requires,
in addition to flbD, synthesis of the switch proteins, the
M-ring protein, and all other level II genes (refs. 1 and 2;
G.R., J. Zhao, and A.N., unpublished results). Mutations in
any ofthem prevent Ea54-dependent transcription of genes at
levels III and IV, presumably because basal-body assembly
cannot be completed. In contrast, only the level IIfliF, fliG,
and flbE genes appear to be directly involved in negative
regulation of fliF by flbD: mutations in any of these genes
results in a 5- to 10-fold increase in the levels of fliF
transcription (ref. 1; G.R., J. Zhao, and A.N., unpublished
results). Thus, FlbD activity in vivo must be governed by a
device(s) that senses the expression of other basal-body
genes and/or their assembly into a complete structure.
Whether these controls are exerted through covalent modification, such as phosphorylation, or another mechanism will
require both biochemical and genetic analyses.
FlbD Makes Base-Specific Contacts withftrlf*tl, andofrE.
Dimethyl sulfate footprinting reveals specific interactions of
bound FlbD with cis-acting ftr sequences that have been
shown genetically (3, 9, 10, 12, 19) to govern transcription
from levels II and III promoters. The dimethyl sulfate footprints of F1bD at ftr), ftrl*, and ftr4 demonstrate that FlbD
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binds near to conserved symmetrical guanine residues on
both strands ofthese sequences (see marked guanine residues
in Fig. 1C), and the contact sites within eachftr sequence lie
in regions of near-dyad symmetry [C(C/G)CGGCA(G/A)A]
that span consecutive major grooves. The symmetry of
methylation protection suggests that FMbD, which contains a
putative helix-turn-helix motif, binds to the ftr sequence as
a dimer with each monomer contacting one half-site; such a
mechanism is supported by crystallographic analysis of several bacterial transcription factors containing helix-turnhelix motifs (37-39).
The helical arrangement of the adjacent ftr) and ftrl*,
which are spaced 33 bp from center to center of the adjacent
elements, is strikingly similar to that of the two adjacent
high-affinity binding sites for NtrC at the glnAp2 promoter
(40, 41). Binding of NtrC to these sites at glnAp2 generates
maximum activation of transcription by Eo54 and may constitute a mechanism for the formation of an oligomeric NtrC
complex that catalyzes ATP hydrolysis and potentiates
isomerization of the closed Eo54 complex into the open
complex (33-35). We have now obtained evidence in vitro
that ftrl* is required for flbG transcription (unpublished
results) and believe that theftr)/fitrl* pair plays a similar role
in activator binding and function.
Role ofFbD in Rulatin of thefla Gene Hierarchy. Based
on our analysis of FlbD binding at fir), ftrl*, and fitr4, we
have now identified 19-bp sequence elements that are very
similar to these FlbD binding sites at about -100 of each level
m and IVfla gene promoters (36). Highly conserved nucleotides include the guanine residues that are specifically
contacted by the FlbD protein atftrl, ftrl*, andftr4 and the
A+T-rich central core. With the exception of the fliL promoter, these' putative ftr sequences are organized in pairs
with approximately'three helical turns between centers ofthe
adjacent sites. It is our hypothesis that FlbD functions at
these sequences as a key component of the developmental
switch whose activity during a specific stage of the cell cycle
is required to establish repression of class II genes transcribed from thefliF promoter and to act as a global activator
of transcription from the Eo54-dependent promoters of class
III and class'IV genes.
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